What Is Lactobacillus gasseri?
Lactobacillus gasseri (also abbreviated as L. gasseri) is a gram-positive, rod-shaped, facultative anaerobe belonging to the Lactobacillus genus within the Firmicutes phylum. Commonly isolated from the human gastrointestinal tract, oral cavity, and urogenital system, L. gasseri is recognized for its probiotic potential and unique ability to colonize mucosal surfaces. As a core species of the vaginal and intestinal microbiota, L. gasseri plays a critical role in maintaining microbiome homeostasis through lactic acid production and pathogen exclusion.
Due to its adaptive metabolic capacity and immunomodulatory properties, L. gasseri probiotic strains have become focal points in functional microbiome research and are increasingly included in next-generation probiotic formulations. At Creative Biolabs, comprehensive microbial characterization and custom probiotic development services support research surrounding this powerful probiotic species.
Microbiological Profile of L. gasseri
L. gasseri is phylogenetically close to L. johnsonii and is considered a member of the L. acidophilus group. Its genome, typically around 1.8 Mb, encodes various genes responsible for carbohydrate metabolism, bacteriocin production (e.g., gassericin A and T), and surface-layer proteins involved in host adhesion.
Key features include:
-
Lactic Acid Production: Acidifies the local environment, creating unfavorable conditions for pathogens.
-
Bacteriocin Secretion: Produces antimicrobial peptides targeting gram-negative and gram-positive pathogens.
-
Adhesion Capacity: Surface proteins enable binding to intestinal epithelial cells, enhancing persistence and colonization.
-
Autochthony: As a native inhabitant of human gut flora, it maintains long-term compatibility and metabolic adaptability.
These characteristics make L. gasseri probiotics ideal for strain-specific functional applications and personalized microbiome strategies.
Mechanisms of Action: How L. gasseri Functions as a Probiotic
The probiotic L. gasseri exerts multiple physiological effects through diverse mechanisms. These include:
1. Modulation of Gut Microbiota Composition
Probiotic L. gasseri enhances the abundance of beneficial microbes while suppressing opportunistic pathogens like Escherichia coli, Clostridium difficile, and Helicobacter pylori. This ecological rebalancing is partly mediated by competitive exclusion and acidification of the gut milieu.
Though not a major SCFA producer, L. gasseri contributes to the metabolic interplay in the gut, promoting butyrate-producing bacteria through cross-feeding pathways.
3. Regulation of Immune Responses
L. gasseri modulates host immunity by interacting with dendritic cells and intestinal epithelial cells. It can influence cytokine expression (e.g., IL-10, TGF-β), promote IgA production, and reduce pro-inflammatory signaling, which is vital for immune homeostasis.
4. Strengthening of Gut Barrier Integrity
By upregulating tight junction proteins (e.g., occludin, claudins), L. gasseri helps maintain epithelial integrity, preventing translocation of antigens and reducing systemic immune activation.
Health Benefits of L. gasseri
While L. gasseri is not approved for therapeutic use, extensive scientific investigations suggest a range of potential benefits associated with its presence in the microbiota.
Weight Regulation & Metabolic Modulation
Some clinical studies report that strains like L. gasseri SBT2055 may support weight management by influencing lipid metabolism, reducing visceral fat mass, and modulating adipocytokines. These effects are likely mediated via gut microbiota restructuring and alterations in bile acid metabolism.
Gastrointestinal Function and Comfort
L. gasseri contributes to gastrointestinal well-being by enhancing peristalsis, balancing intestinal flora, and reducing occasional bloating or discomfort. It also helps suppress H. pylori colonization, an organism implicated in gastric irritation.
Immune System Support
Probiotic with L. gasseri has been shown to prime mucosal immunity, particularly enhancing IgA secretion and balancing Th1/Th2 responses. These features are essential in respiratory tract health and systemic immune regulation.
Female Urogenital Health
As a natural constituent of the vaginal microbiota, L. gasseri helps lower vaginal pH and inhibit the growth of Candida albicans and Gardnerella vaginalis. Its adhesion to epithelial cells also blocks pathogen attachment, contributing to microbial equilibrium in the urogenital tract.
Application in Next-Generation Probiotic Formulations
As the probiotic market transitions from broad-spectrum blends to precision-targeted strains, L. gasseri is gaining recognition as a valuable core species for next-generation synbiotics and customized consortia.
Strain-Specific Formulation
Different L. gasseri strains exhibit diverse functionalities. For example:
|
Strain
|
Functional Focus
|
Notable Features
|
|
SBT2055
|
Metabolic balance
|
Anti-adiposity, bile salt hydrolase activity
|
|
OLL2809
|
Immunomodulation
|
Increased IL-10 and regulatory T cell activation
|
|
LA806
|
Gut health
|
Improved barrier integrity and SCFA modulation
|
Creative Biolabs offers L. gasseri strain isolation, microbial identification, genome sequencing, and phenotype profiling to support researchers in selecting the most suitable strains for their studies.
Encapsulation and Delivery Optimization
To preserve viability and functional activity, L. gasseri probiotics often require microencapsulation or freeze-drying techniques. Creative Biolabs supports custom formulation design, including encapsulation in acid-resistant coatings and shelf-stable powder production for research applications.
Custom Fermentation and Biomass Scale-Up
Fermentation conditions—such as pH, temperature, and carbon source—critically influence biomass yield and metabolite expression. Creative Biolabs provides fermentation process optimization and scale-up services tailored to L. gasseri production, ensuring strain integrity and high cell counts.
Scientific Challenges and Considerations
Despite its potential, the incorporation of L. gasseri bacteria into probiotic products must address several technical and regulatory considerations:
-
Strain Stability: Genetic drift can alter phenotypic properties over time, requiring ongoing quality assurance. To address this challenge, Creative Biolabs offers comprehensive L. gasseri strain stability testing services, including long-term storage validation, genomic consistency checks, and viability monitoring under various environmental conditions.
-
Functional Verification: In vitro effects may not always translate into host-associated settings, highlighting the need for standardized assays. Creative Biolabs supports this critical step by providing tailored L. gasseri functional screening and mechanism of action (MoA) analysis services, helping researchers validate strain-specific activities and elucidate host–microbe interaction pathways.
-
Regulatory Compliance: For research use only, all L. gasseri preparations must comply with local biosafety and quality standards.
Creative Biolabs implements a robust quality management system for all probiotic-related services, from cell bank preparation to post-fermentation stability testing.
FAQs
How does L. gasseri contribute to gut health in experimental models?
It regulates intestinal microbiota, inhibits pathogens, supports mucosal immunity, and enhances barrier integrity, providing a multifaceted approach to maintaining gut ecosystem balance in both in vitro and in vivo models.
What distinguishes different L. gasseri strains in research applications?
Strain-specific traits such as bacteriocin profiles, bile salt hydrolase activity, and immunomodulatory capacity vary widely, requiring genomic and functional screening to select the optimal candidate for each research focus.
Can L. gasseri be co-formulated with other probiotics in research formulations?
Yes, it is often used in combination with other Lactobacillus or Bifidobacterium strains. Creative Biolabs offers support for co-formulation strategies and compatibility testing to ensure synergistic effects in designed consortia.
Related Resources
References
-
Kadooka, Yukio, et al. "Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial." British Journal of Nutrition 110.9 (2013): 1696-1703. https://doi.org/10.1017/S0007114513001037
-
Gebremariam, Hanna G., et al. "Lactobacillus gasseri suppresses the production of proinflammatory cytokines in Helicobacter pylori-infected macrophages by inhibiting the expression of ADAM17." Frontiers in Immunology 10 (2019): 2326. https://doi.org/10.3389/fimmu.2019.02326
